Satoshi Kawaai
St. Luke's International Hospital
Tokyo, Japan
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and safety of canakinumab in patients with adult-onset Still's disease: Results from an open-label phase III study in Japan.
Journal: Modern rheumatology
Published: November 27, 2025
Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey.
Journal: Modern rheumatology
Published: July 24, 2024
Bone marrow edema detection for diagnostic support of axial spondyloarthritis using MRI.
Journal: International journal of computer assisted radiology and surgery
Published: December 02, 2023
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).
Journal: Expert review of clinical immunology
Published: November 13, 2023
Current evidence and practical knowledge for ultrasound-guided procedures in rheumatology: Joint aspiration, injection, and other applications.
Journal: Best practice & research. Clinical rheumatology
Published: April 24, 2023
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
Journal: Modern rheumatology
Published: December 19, 2022
Advantages of an alternate-day glucocorticoid treatment strategy for the treatment of IgG4-related disease: A preliminary retrospective cohort study.
Journal: Medicine
Published: October 01, 2022
A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with review.
Journal: Modern rheumatology case reports
Published: January 17, 2022
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis.
Journal: Rheumatology international
Published: January 17, 2022
A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet's disease.
Journal: Scandinavian journal of rheumatology
Published: July 07, 2021
Effectiveness and safety of mizoribine for the treatment of IgG4-related disease: a retrospective cohort study.
Journal: Rheumatology (Oxford, England)
Published: October 30, 2020
Last Updated: 09/26/2026